Enovis Cash Flow Statement
NYSE: ENOVHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Enovis free cash flow
In fiscal 2025, Enovis generated $217.3 million of operating cash flow and spent $197.4 million on capital expenditures. That left free cash flow of $19.9 million, a free-cash-flow margin of 0.9% of revenue. Enovis returned $3.5 million to shareholders through share repurchases, equal to 18% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Enovis cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1.18B | -824.82M | -32.73M | -11.76M | 76.28M | 45.77M | -517.15M | 154.47M | 169.51M | 145.19M |
| Net Income growth (YoY) | — | — | — | -115.42% | +66.65% | — | -434.78% | -8.87% | +16.75% | -22.43% |
| Depreciation & Amortization | 1.34B | 927.83M | 217.11M | 202.97M | 186.99M | 167.90M | 215.61M | 81.21M | 72.69M | 128.83M |
| Stock-Based Compensation | 32.92M | 29.66M | 34.06M | 38.95M | 35.35M | 28.91M | 21.96M | 25.10M | 21.55M | 19.02M |
| Change in Working Capital | -23.87M | -4.00M | -47.69M | -175.82M | -62.48M | 35.73M | -114.29M | -49.48M | -68.10M | 5.79M |
| Operating Cash Flow | 217.29M | 113.50M | 134.99M | -55.86M | 356.10M | 301.94M | 130.95M | 226.37M | 218.77M | 246.97M |
| Capital Expenditures | -197.38M | -180.71M | -122.22M | -105.45M | -104.24M | -114.78M | -125.40M | -69.65M | -68.77M | -63.25M |
| Investing Cash Flow | -179.37M | -955.47M | -242.47M | -176.39M | -320.48M | -175.08M | -1.63B | -167.85M | 89.88M | -81.99M |
| Share Repurchases | -3.50M | -4.77M | 0 | 0 | — | 0 | 0 | -200.00M | 0 | -20.81M |
| Debt Issued | — | — | — | — | — | 0 | 1.00B | 0 | 374.45M | 0 |
| Debt Repaid | — | 0 | 0 | -686.28M | 0 | -40.00M | -1.39B | -131.25M | -65.63M | -37.50M |
| Financing Cash Flow | -52.40M | 846.82M | 127.80M | -465.13M | 584.91M | -131.65M | 1.37B | -47.15M | -280.45M | -145.22M |
| Net Change in Cash | -11.78M | 3.33M | 20.54M | -695.08M | 618.30M | -8.56M | -135.39M | -17.00M | 40.29M | 24.26M |
| Free Cash Flow | 19.92M | -67.21M | 12.77M | -161.31M | 251.86M | 187.15M | 5.55M | 156.72M | 150.00M | 183.72M |
This table shows 10 annual periods of Enovis's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ENOV's reporting calendar. What is a cash flow statement?